Carl Zeiss Meditec sees FY 2025/26 revenue at EUR 2.15-2.2 billion

Reuters2026/08/06 06:20

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Carl Zeiss Meditec forecast FY 2025/26 revenue of at least EUR 2.15-2.2 billion.
Adjusted EBITA margin seen at 8%-10%, adjusted for mid double-digit EUR million special effects.
Expected Q4 goodwill impairment of about EUR 150 million for the Ophthalmology strategic business unit.
Guidance follows 9M revenue of EUR 1.55 billion, adjusted EBITA margin of 8%, pressured by FX and product mix.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Carl Zeiss Meditec AG published the original content used to generate this news brief on August 05, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Carl Zeiss Meditec sees FY 2025/26 revenue at EUR 2.15-2.2 billion

You may also like

Crypto prices